|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global Cancer Statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gumireddy K, Li A, Gimotty PA,
Klein-Szanto AJ, Showe LC, Katsaros D, et al: KLF17 is a negative
regulator of epithelial-mesenchymal transition and metastasis in
breast cancer. Nat Cell Biol. 11:1297–1304. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Haber DA, Buckler AJ, Glaser T, Call KM,
Pelletier J, Sohn RL, et al: An internal deletion within an 11p13
zinc finger gene contributes to the development of Wilms’ tumor.
Cell. 61:1257–1269. 1990.PubMed/NCBI
|
|
5
|
Little M and Wells C: A clinical overview
of WT1 gene mutations. Hum Mutat. 9:209–225. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Loeb DM and Sukumar S: The role of WT1 in
oncogenesis: tumor suppressor or oncogene? Int J Hematol.
76:117–126. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hohenstein P and Hastie ND: The many
facets of the Wilms’ tumour gene, WT1. Hum Mol Genet. 15:R196–R201.
2006.PubMed/NCBI
|
|
8
|
Yang L, Han Y, Suarez Saiz F and Minden
MD: A tumor suppressor and oncogene: the WT1 story. Leukemia.
21:868–876. 2007.PubMed/NCBI
|
|
9
|
Sugiyama H: WT1 (Wilms’ tumor gene 1):
biology and cancer immunotherapy. Jpn J Clin Oncol. 40:377–387.
2010.
|
|
10
|
Huff V: Wilms’ tumours: about tumour
suppressor genes, an oncogene and a chameleon gene. Nat Rev Cancer.
11:111–121. 2011.
|
|
11
|
Oji Y, Ogawa H, Tamaki H, Oka Y, Tsuboi A,
Kim EH, et al: Expression of the Wilms’ tumor gene WT1 in solid
tumors and its involvement in tumor cell growth. Jpn J Cancer Res.
90:194–204. 1999.
|
|
12
|
Silberstein GB, Van Horn K, Strickland P,
Roberts CT Jr and Daniel CW: Altered expression of the WT1 wilms
tumor suppressor gene in human breast cancer. Proc Natl Acad Sci
USA. 94:8132–8137. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang TF, Yu SQ, Guan LS and Wang ZY:
Inhibition of breast cancer cell growth by the Wilms’ tumor
suppressor WT1 is associated with a destabilization of
beta-catenin. Anticancer Res. 23:3575–3584. 2003.
|
|
14
|
Reizner N, Maor S, Sarfstein R,
Abramovitch S, Welshons WV, Curran EM, et al: The WT1 Wilms’ tumor
suppressor gene product interacts with estrogen receptor-alpha and
regulates IGF-I receptor gene transcription in breast cancer cells.
J Mol Endocrinol. 35:135–144. 2005.
|
|
15
|
Wang L and Wang ZY: The Wilms’ tumor
suppressor WT1 inhibits malignant progression of neoplastigenic
mammary epithelial cells. Anticancer Res. 28:2155–2160. 2008.
|
|
16
|
Oji Y, Miyoshi Y, Kiyotoh E, Koga S,
Nakano Y, Ando A, et al: Absence of mutations in the Wilms’ tumor
gene WT1 in primary breast cancer. Jpn J Clin Oncol. 34:74–77.
2004.
|
|
17
|
Loeb DM, Evron E, Patel CB, Sharma PM,
Niranjan B, Buluwela L, et al: Wilms’ tumor suppressor gene (WT1)
is expressed in primary breast tumors despite tumor-specific
promoter methylation. Cancer Res. 61:921–925. 2001.
|
|
18
|
Miyoshi Y, Ando A, Egawa C, Taguchi T,
Tamaki Y, Tamaki H, et al: High expression of Wilms’ tumor
suppressor gene predicts poor prognosis in breast cancer patients.
Clin Cancer Res. 8:1167–1171. 2002.
|
|
19
|
Zapata-Benavides P, Tuna M,
Lopez-Berestein G and Tari AM: Downregulation of Wilms’ tumor 1
protein inhibits breast cancer proliferation. Biochem Biophys Res
Commun. 295:784–790. 2002.
|
|
20
|
Tuna M, Chavez-Reyes A and Tari AM:
HER2/neu increases the expression of Wilms’ Tumor 1 (WT1) protein
to stimulate S-phase proliferation and inhibit apoptosis in breast
cancer cells. Oncogene. 24:1648–1652. 2005.
|
|
21
|
Caldon CE, Lee CS, Sutherland RL and
Musgrove EA: Wilms’ tumor protein 1: an early target of progestin
regulation in T-47D breast cancer cells that modulates
proliferation and differentiation. Oncogene. 27:126–138. 2008.
|
|
22
|
Han Y, Yang L, Suarez-Saiz F, San-Marina
S, Cui J and Minden MD: Wilms’ tumor 1 suppressor gene mediates
antiestrogen resistance via down-regulation of estrogen
receptor-alpha expression in breast cancer cells. Mol Cancer Res.
6:1347–1355. 2008.
|
|
23
|
Camcı C, Kalender ME, Paydaş S, Sevinç A,
Zorludemir S and Suner A: Prognostic significance of Wilms Tumor 1
(WT1) protein expression in breast cancer. Gaziantep Med J.
17:67–72. 2011.
|
|
24
|
Sabatier R, Finetti P, Cervera N,
Lambaudie E, Esterni B, Mamessier E, et al: A gene expression
signature identifies two prognostic subgroups of basal breast
cancer. Breast Cancer Res Treat. 126:407–420. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Finetti P, Cervera N, Charafe-Jauffret E,
Chabannon C, Charpin C, Chaffanet M, et al: Sixteen-kinase gene
expression identifies luminal breast cancers with poor prognosis.
Cancer Res. 68:767–776. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Irizarry RA, Hobbs B, Collin F,
Beazer-Barclay YD, Antonellis KJ, Scherf U, et al: Exploration,
normalization, and summaries of high density oligonucleotide array
probe level data. Biostatistics. 4:249–264. 2003. View Article : Google Scholar
|
|
27
|
Nie H, Neerincx PB, van der Poel J,
Ferrari F, Bicciato S, Leunissen JA, et al: Microarray data mining
using Bioconductor packages. BMC Proc. 3:S92009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Crawford JR and Garthwaite PH: Single-case
research in neuropsychology: A comparison of five forms of t-test
for comparing a case to controls. Cortex. Jul 23–2011.(Epub ahead
of print).
|
|
29
|
Diboun I, Wernisch L, Orengo CA and
Koltzenburg M: Microarray analysis after RNA amplification can
detect pronounced differences in gene expression using limma. BMC
Genomics. 7:2522006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Perou CM, Sørlie T, Eisen MB, van de Rijn
M, Jeffrey SS, Rees CA, et al: Molecular portraits of human breast
tumours. Nature. 406:747–752. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sørlie T, Perou CM, Tibshirani R, Aas T,
Geisler S, Johnsen H, et al: Gene expression patterns of breast
carcinomas distinguish tumor subclasses with clinical implications.
Proc Natl Acad Sci USA. 98:10869–10874. 2001.PubMed/NCBI
|
|
32
|
Stoll R, Lee BM, Debler EW, Laity JH,
Wilson IA, Dyson HJ, et al: Structure of the Wilms tumor suppressor
protein zinc finger domain bound to DNA. J Mol Biol. 372:1227–1245.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Martínez-Estrada OM, Lettice LA, Essafi A,
Guadix JA, Slight J, Velecela V, et al: Wt1 is required for
cardiovascular progenitor cell formation through transcriptional
control of Snail and E-cadherin. Nat Genet. 42:89–93.
2010.PubMed/NCBI
|
|
34
|
Sera T, Hiasa Y, Mashiba T, Tokumoto Y,
Hirooka M, Konishi I, et al: Wilms’ tumour 1 gene expression is
increased in hepatocellular carcinoma and associated with poor
prognosis. Eur J Cancer. 44:600–608. 2008.
|
|
35
|
Perugorria MJ, Castillo J, Latasa MU, Goni
S, Segura V, Sangro B, et al: Wilms’ tumor 1 gene expression in
hepatocellular carcinoma promotes cell dedifferentiation and
resistance to chemotherapy. Cancer Res. 69:1358–1367. 2009.
|
|
36
|
Tatsumi N, Oji Y, Tsuji N, Tsuda A,
Higashio M, Aoyagi S, et al: Wilms’ tumor gene WT1-shRNA as a
potent apoptosis-inducing agent for solid tumors. Int J Oncol.
32:701–711. 2008.
|
|
37
|
McCarty G, Awad O and Loeb DM: WT1 protein
directly regulates expression of vascular endothelial growth factor
and is a mediator of tumor response to hypoxia. J Biol Chem.
286:43634–43643. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jomgeow T, Oji Y, Tsuji N, Ikeda Y, Ito K,
Tsuda A, et al: Wilms’ tumor gene WT1 17AA(−)/KTS(−) isoform
induces morphological changes and promotes cell migration and
invasion in vitro. Cancer Sci. 97:259–270. 2006.
|
